Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2000
04/05/2000CN1051014C Ginseng and aconite injection and its preparing method
04/05/2000CN1051008C Chinese medicine composition for treatment of coronary heart disease and angina
04/04/2000US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors
04/04/2000US6046340 Imidazole containing pseudodipeptide product and compositions containing the same
04/04/2000US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
04/04/2000US6046329 Uracil derivatives
04/04/2000US6046244 Composition comprising prostaglandin e1, skin penetration enhancer, polysaccharide gum, lipophilic compound, acidic buffer system
04/04/2000US6046237 Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments
04/04/2000US6046233 Agent for treating cor pulmonale
04/04/2000US6046213 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives
04/04/2000US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors
04/04/2000US6046205 For treatment of venous insufficiency and of associated disorders, and also in the treatment of migraine
04/04/2000US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus
04/04/2000US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
04/04/2000US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae
04/04/2000US6046172 Hydrolytically processed oligodeoxyribonucleotides and their pharmaceutical compositions
04/04/2000US6046166 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
04/04/2000US6046162 Suppression of cell proliferation by decorin
04/04/2000US6046161 Use of hemoglobin in the treatment of cardiogenic shock
04/04/2000US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such
04/04/2000US6046022 Methods and compositions employing red rice fermentation products
04/04/2000US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis
04/04/2000CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins
04/04/2000CA2136607C Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer
04/04/2000CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
04/04/2000CA1340948C Peptidylaminodiols
04/04/2000CA1340940C Peptidylaminodiols
03/2000
03/30/2000WO2000017394A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
03/30/2000WO2000017393A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
03/30/2000WO2000017392A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017361A2 Interferon-epsilon
03/30/2000WO2000017358A2 Human chaperone proteins
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017328A2 Fibrils
03/30/2000WO2000017229A1 Process for the preparation of n2-(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline
03/30/2000WO2000017228A2 Stereoselective process for enalapril
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017204A1 INHIBITORS OF p38
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000WO2000017176A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
03/30/2000WO2000017175A1 INHIBITORS OF p38
03/30/2000WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000WO2000017166A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000WO2000017165A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000WO2000017159A1 Arylsulfonanilide ureas
03/30/2000WO2000016797A2 Use of glp-1 or analogs in treatment of stroke
03/30/2000WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors
03/30/2000WO2000016760A2 New use of prostaglandin e2 antagonists
03/30/2000WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
03/30/2000WO2000002576A3 Egf-genistein for prevention of restenosis
03/30/2000WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
03/30/2000WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments
03/30/2000CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344556A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2344056A1 Use of glp-1 or analogs in treatment of stroke
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343193A1 Improved stereoselective process for enalapril
03/30/2000CA2342773A1 Interferon-epsilon
03/30/2000CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000CA2311407A1 Process for the preparation of n2-(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline
03/29/2000EP0988320A1 Cyclic crf agonists
03/29/2000EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988295A1 Heterocyclic substituted piperidines and uses thereof
03/29/2000EP0988282A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
03/29/2000EP0988038A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
03/29/2000EP0988035A1 Caspases and apoptosis
03/29/2000EP0987997A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
03/29/2000EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses
03/29/2000EP0620733B1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof
03/29/2000CN1248971A Quinoxalinediones
03/29/2000CN1248966A Aminobenzophenones as inhibitors of interleukin and TNF
03/29/2000CN1050844C Protein kinase C inhibitors
03/29/2000CN1050841C Indole derivatives and medicinal composition having same
03/29/2000CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/29/2000CN1050830C Hydroxy-substituted azetidinone compounds and its use in medicine
03/29/2000CN1050750C Useof magnesium-pyridoxal-5'-phosphate-glutaminate for prevention of diseases which result fromvascular lesions
03/28/2000US6043366 Useful in treating disorders involving the orphanin fq(a seventeen amino acid long peptide) receptor.
03/28/2000US6043284 Anti-atherosclerotic diaryl compounds
1 ... 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 ... 1595